🇺🇸 FDA
Patent

US 12134631

Hydrophilic linkers for antibody drug conjugates

granted A61KA61K31/566A61K31/58

Quick answer

US patent 12134631 (Hydrophilic linkers for antibody drug conjugates) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/566, A61K31/58, A61K47/549, A61K47/554